Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 270,200 | 291,100 | 395,400 | 109,500 | 251,400 |
| Receivables | 36,100 | 71,500 | 32,500 | 110,700 | 30,400 |
| Inventories | 17,600 | 18,300 | 16,200 | 17,800 | 15,600 |
| Income taxes - deferred | 17,300 | 18,000 | 12,000 | 11,400 | 15,400 |
| TOTAL | $367,000 | $420,500 | $478,300 | $264,200 | $333,900 |
| Non-Current Assets | |||||
| PPE Net | 1,512,600 | 1,548,800 | 1,435,300 | 1,463,200 | 1,469,000 |
| Intangibles | 374,600 | 375,500 | 295,200 | 301,800 | 198,800 |
| Other Non-Current Assets | 254,100 | 263,600 | 243,000 | 192,900 | 196,400 |
| TOTAL | $2,141,300 | $2,187,900 | $1,973,500 | $1,957,900 | $1,864,200 |
| Total Assets | $2,508,300 | $2,608,400 | $2,451,800 | $2,222,100 | $2,198,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,400 | 24,900 | 19,500 | 22,000 | 21,800 |
| Accounts payable and accrued liabilities | 109,500 | 201,000 | 132,900 | 157,000 | 104,100 |
| Accrued Expenses | 105,300 | 124,000 | 74,300 | 106,300 | 74,200 |
| TOTAL | $313,000 | $441,700 | $361,200 | $451,900 | $256,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,185,800 | 2,189,400 | 2,158,700 | 1,912,400 | 1,915,100 |
| Deferred Revenues | 56,400 | 91,800 | 119,900 | 166,600 | 56,400 |
| Other Non-Current Liabilities | 203,800 | 205,600 | 200,800 | 198,300 | 172,300 |
| TOTAL | $2,853,800 | $2,864,600 | $2,796,800 | $2,520,600 | $2,494,000 |
| Total Liabilities | $3,166,800 | $3,306,300 | $3,158,000 | $2,972,500 | $2,750,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 155,832 | 155,824 | 155,856 | 155,799 | 155,457 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 80,500 | 38,300 | 15,100 | 1,100 | 33,400 |
| Other shareholders' equity | -5,900 | -1,900 | -3,800 | -6,100 | -7,600 |
| TOTAL | $-658,500 | $-697,900 | $-706,200 | $-750,400 | $-552,400 |
| Total Liabilities And Equity | $2,508,300 | $2,608,400 | $2,451,800 | $2,222,100 | $2,198,100 |